Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Diabetes mellitus is a chronic disease with high prevalence worldwide and a range of serious related complications. Amongst them, diabetic foot is one of the most disabling, posing a substantial health and economic burden on patients and healthcare systems. Areas covered: According to projections, the expected lower limb morbidity is about to increase - in this light the present review aimed at identifying cost-of-illness studies on the management and treatment of conditions related to the diabetic foot, in an aim to provide a body of evidence for an increasing health care burden. Expert commentary: Recent literature review surfaced a plethora of cost studies. Despite heterogeneity of foot complications and geographic variations, the search methodology revealed substantial costs and further healthcare burden for people with diabetes. Amputations due to suboptimally treated foot infections contribute to the already high rates of hospitalizations and readmissions. The cost of amputation ranges between $35,000 and $45,000 in the developed countries, however it largely depends on the amputation type. Moreover, the findings suggest that the cost of amputation in the US is generally higher compared to the cost in European countries. The cost of amputation in developing countries is substantially lower, as it approximates $5,000.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Five steps to conducting a systematic review
Khan, K. S., Kunz, R., Kleijnen, J., & Antes, G. (2003) · Journal of the Royal Society of Medicine · doi:10.1177/014107680309600304 · Cited by 1,873 · cited 1×
“A clearly formulated research question and a systematic approach through the identification of relevant studies according to well-defined inclusion and quality criteria are the main characteristics of such reviews [11].”
BackgroundSystematic reviews and meta-analysis: Understanding the best evidence in primary healthcare
Ganeshkumar, P., & Gopalakrishnan, S. (2013) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.109934 · Cited by 743
Burden of Diabetic Foot Ulcers for Medicare and Private Insurers
Rice, J. B., Desai, U., Cummings, A. K. G., Birnbaum, H. G., Skornicki, M., & Parsons, N. B. (2014) · Diabetes Care · doi:10.2337/dc13-2176 · Cited by 624 · cited 1×
“Apart from the above, for privately insured patients, the prescription drug and total indirect costs were estimated at $4959 and $6896, respectively [37].”
BackgroundCost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
Li, R., Zhang, P., Barker, L. E., Chowdhury, F. M., & Zhang, X. (2010) · Diabetes Care · doi:10.2337/dc10-0843 · Cited by 491
Sargen, M. R., Hoffstad, O., & Margolis, D. J. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.09.003 · Cited by 93
Cited by
The cost of diabetic foot ulcers and amputations to the National Health Service in England
Kerr, M., Barron, E., Chadwick, P., Evans, T., Kong, W. M., Rayman, G., Sutton‐Smith, M., Todd, G., Young, B., & Jeffcoate, W. J. (2019) · Diabetic Medicine · doi:10.1111/dme.13973 · Cited by 458
The current burden of diabetic foot disease
Edmonds, M., Manu, C., & Vas, P. (2021) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2021.01.017 · Cited by 437
Geiss, L. S., Li, Y., Hora, I., Albright, A., Rolka, D., & Gregg, E. W. (2019) · Diabetes Care · doi:10.2337/dc18-1380 · Cited by 319
Edmonds, M., Lázaro-Martínez, J. L., Alfayate-García, J. M., Martini, J., Petit, J.-M., Rayman, G., Lobmann, R., Uccioli, L., Sauvadet, A., Bohbot, S., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30438-2 · Cited by 275
Dhatariya, K., Bain, S. C., Buse, J. B., Simpson, R., Tarnow, L., Kaltoft, M. S., Stellfeld, M., Tornøe, K., Pratley, R. E., & the LEADER Publication Committee on behalf of the LEADER Trial Investigators (2018) · Diabetes Care · doi:10.2337/dc18-1094 · Cited by 141
Metadata
- Authors
- Petrakis, I., Kyriopoulos, I. J., Ginis, A., & Athanasakis, K.
- Venue
- Expert Review of Pharmacoeconomics & Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2017-03-04
- Volume
- 17
- Issue
- 2
- Pages
- 165-180
- ISSN
- 1473-7167 (ISSN-L)
- 1744-8379
- OpenAlex
- W2592287304
- Cited by
- 68
- References
- 5
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications. https://app.cochat.ai/papers/10.1080/14737167.2017.1305891
- The paper
- Petrakis, I., Kyriopoulos, I. J., Ginis, A., & Athanasakis, K. (2017). Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2017.1305891
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.